{{Rsnum
|rsid=16934131
|Gene=KCNMA1
|Chromosome=10
|position=78737595
|Orientation=plus
|GMAF=0.1736
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 8.0 | 40.7 | 51.3
| HCB | 0.0 | 8.0 | 92.0
| JPT | 0.0 | 0.9 | 99.1
| YRI | 2.0 | 25.9 | 72.1
| ASW | 3.5 | 19.3 | 77.2
| CHB | 0.0 | 8.0 | 92.0
| CHD | 0.0 | 1.9 | 98.1
| GIH | 6.9 | 35.6 | 57.4
| LWK | 0.9 | 31.2 | 67.9
| MEX | 1.7 | 22.4 | 75.9
| MKK | 0.6 | 20.5 | 78.8
| TSI | 2.9 | 47.1 | 50.0
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs16934131
|Name_s=
|Gene_s=KCNMA1
|Feature=
|Evidence=PubMed ID:17553421; PubMed ID:19118814
|Annotation=This variant is nominally associated with late-onset Alzheimer disease (LOAD) in 2 GWAS studies.
|Drugs=
|Drug Classes=
|Diseases=Alzheimer Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA162363850
}}

{{PMID Auto
|PMID=21480501
|Title=Replication study of genome-wide associated SNPs with late-onset Alzheimer's disease.
|OA=1
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs16934131
|overall_frequency_n=23
|overall_frequency_d=128
|overall_frequency=0.179688
|n_genomes=19
|n_genomes_annotated=0
|n_haplomes=20
|n_articles=0
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}